Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Millennium Pharmacon International Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Millennium Pharmacon International Tbk. diperdagangkan di Rp179 (kapitalisasi pasar 230,59 M, volume 24 jam 19,2 rb). Perbedaan utamanya: Millennium Pharmacon International Tbk. lebih besar dari sisi kapitalisasi pasar, dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 19,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SDPC | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 230,59 M |
Volume | 592,2 rb | 19,2 rb |
Lot | 5,92 rb | 192 |
Perputaran | 147,05 jt | 3,43 jt |
Harga Rata-rata | 248,31 | 178,62 |
Nilai Transaksi | 147,05 jt | 3,43 jt |
Harga Ekuilibrium Indikatif | 254 | — |
Volume Ekuilibrium Indikatif | 10 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Selengkapnya di halaman SDPC →